Blood Journal

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Blood Journal
Sep 8, 2024, 08:29 | Blog
Talha Badar: Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ ALL
Talha Badar shared a post on X, about recent paper published in Blood Neoplasia: Cerebrospinal…
Aug 31, 2024, 10:03 | Insight
Myeloma Paper of the Day, August 31st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Updated KarMMa-3 analyses shows Ide-cel…
Aug 30, 2024, 10:57 | Insight
Myeloma Paper of the Day, August 30th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: International retrospective cohort study to…
Aug 25, 2024, 09:29 | Insight
Rahul Banerjee: Fascinating Multiple Myeloma results of MajesTEC-1 in BCMA-exposed patients
Rahul Banerjee shared a post by Robert Z. Orlowski, Director of Myeloma Section at MD Anderson…
Aug 19, 2024, 10:38 | Insight
Hagop Kantarjian: All you need to know about the latest JAK inhibitor to be approved for myelofibrosis
Hagop Kantarjian shared a post on X about a recent paper by Prithviraj Bose published…
Aug 19, 2024, 10:29 | Insight
New ELN classification of AML receiving less intense therapies
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about…
Aug 10, 2024, 12:42 | Blog
Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva
Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:  "EXCELLENT Blood…
Jul 28, 2024, 12:28 | Insight
Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…
Jul 15, 2024, 21:23 | Insight
Herculean effort on risk prediction model for clonal cytopenias
UChicago Leukemia Program shared a post on X about a recent paper by Zhuoer Xie et…
Jul 14, 2024, 22:08 | Blog
Rahul Banerjee: IL-18: magnifying glass, rejuvenating cream, and phone-a-friend all in one for T cells
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: ''Fascinating MMsm work…
Jul 8, 2024, 01:07 | Blog
Konstantinos Kokkaliaris: Niche-centric strategies to revert aging and chemotherapy-related hematopoietic decline
Konstantinos Kokkaliaris, Junior group leader at Dr. Senckenberg Institute of Pathology, shared a post on…
Jul 1, 2024, 14:22 | Insight
Ponatinib CSF concentrations in Ph+ ALL
Anand Patel shared on X: "Very informative paper in Blood Journal looking at ponatinib CSF concentrations…
Jun 30, 2024, 13:19 | Blog
Apply now to organize a Poster Walk for ASH24
ASH shared a post on X: “Apply now to organize a Poster Walk for ASH24!…
May 25, 2024, 12:44 | Blog
Emma M. Groarke: Excited to see our collaboration looking at VTE in VEXAS syndrome out in this issue of Blood Journal!
Emma M. Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on…
May 24, 2024, 01:21 | Insight
Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval
Sylvester-led analysis on minimal residual disease as clinical endpoint guided committee decision A U.S. Food…
Mar 25, 2024, 05:56 | Insight
Carmelo Gurnari: Overexcited for this achievement shedding new insights into PNH clinico-biological features
Carmelo Gurnari, Hematologist/Oncologist and Researcher at Cleveland Clinic, posted on X: "Overexcited for this achievement…
Mar 17, 2024, 13:43 | Insight
Samer Al Hadidi: How to counsel patients about Cilta Cel
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X/Twitter:…
Feb 8, 2024, 14:58 | Blog
Emma M. Groarke: We found that there was more than 40% cumulative incidence of venous and arterial thrombosis in patients with VEXAS
Emma M. Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on…
Nov 28, 2023, 23:04 | Insight
Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
Juan P. Alderuccio, Lymphoma Physician at Sylvester Comprehensive Cancer Center, made the following post on…
Nov 13, 2023, 13:43 | Drugs
Jayastu Senapati: Check out the commentary to our paper in the Blood Journal by Paresh Vyas
Jayastu Senapati, Leukemia fellow at MD Anderson Cancer Centre, shared on X/Twitter: "Check out the…
Nov 7, 2023, 18:03 | Insight
Lachelle Dawn: Excited to share our review article in Blood Journal on the Causes and Consequences of Clonal Hematopoiesis
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on Twitter: "Excited to share…
All: 21 Posts: 1 - 100
Special Coverage